4.6 Review

Perspectives on the Application of Cytogenomic Approaches in Chronic Lymphocytic Leukaemia

Related references

Note: Only part of the references are listed.
Article Hematology

Optical genome mapping in acute myeloid leukemia: a multicenter evaluation

Brynn Levy et al.

Summary: The detection of key genetic abnormalities in acute myeloid leukemia (AML) is crucial for accurate diagnosis, prognosis, and patient management. However, current cytogenetic techniques such as karyotyping and fluorescence in situ hybridization (FISH) are limited by their reliance on skilled personnel, time, cost, and labor. Optical genome mapping (OGM) offers a single, cost-effective assay with higher resolution than karyotyping and comparable genome-wide analysis to chromosomal microarray analysis (CMA), while also being able to detect balanced structural variants (SVs).

BLOOD ADVANCES (2023)

Article Hematology

Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping

Katrina Rack et al.

Summary: Acute lymphoblastic leukemia (ALL) is a malignant disease that can be divided into distinct subtypes based on clinical and genomic features. Traditional diagnostic methods are laborious and costly. This study applied optical genome mapping (OGM) to diagnose ALL and found that OGM can accurately detect common genomic abnormalities, improve the detection rate and cytogenetic resolution, and reduce turnaround time.

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Article Oncology

Epidemiology of chronic lymphocytic leukemia in Chilean and Amerindian population in Chile

Maria Elena Cabrera et al.

Summary: The study found that CLL patients in Chile have a lower overall survival rate, especially in men, those aged 65 and above, high-risk patients, and those with increased prolymphocytes (CLL/PL). The incidence of CLL in Chile is also lower compared to European countries. Additionally, CLL is very rare in the Amerindian population.

LEUKEMIA & LYMPHOMA (2022)

Review Medicine, Research & Experimental

Venetoclax alone or in combination with other regimens treatment achieve deep and sustained remission of relapsed/refractory chronic lymphocytic leukemia: a meta-analysis

Xiao Tang et al.

Summary: The use of novel targeted drugs has significantly improved the overall response rate and survival of patients with relapsed/refractory chronic lymphocytic leukemia. Venetoclax, especially when combined with anti-CD20 monoclonal antibody, demonstrates effectiveness in treating these patients, particularly those with high-risk cytogenetic factors. Additionally, the combination of ibrutinib with venetoclax shows longer remission times and increased rates of deeper remission and uMRD-negativity with prolonged treatment.

CLINICAL AND EXPERIMENTAL MEDICINE (2022)

Article Oncology

Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study

Yang Ou et al.

Summary: This study evaluated the disease burden of chronic lymphocytic leukemia (CLL) on a global scale and found that the incidence rate of CLL is increasing, while deaths and DALYs are decreasing. The disease burden is influenced by the socio-demographic index (SDI) of different countries, and the male-to-female ratio varies in different SDI quintiles.

FRONTIERS IN ONCOLOGY (2022)

Article Genetics & Heredity

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features

Pauline Robbe et al.

Summary: This study reports the whole-genome sequencing of 485 chronic lymphocytic leukemia patients and identifies a range of recurrent coding and noncoding genetic mutations. The study also provides a high-resolution map of structural variants, copy number changes, and global genome features, and demonstrates the relationship of these features with clinical outcomes.

NATURE GENETICS (2022)

Article Oncology

Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL)

Anna Puiggros et al.

Summary: This study investigated the use of optical genome mapping (OGM) in assessing the cytogenetics of chronic lymphocytic leukemia (CLL). The results showed that OGM can identify most known abnormalities and provide new structural information. OGM had better accuracy than current methods in predicting the time to first treatment. A complex OGM group defined by the number of abnormalities was associated with TP53 abnormalities and shorter time to first treatment.

CANCERS (2022)

Article Hematology

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations

Panagiotis Baliakas et al.

Summary: Cytogenetic analysis has increasing clinical value in CLL, particularly for identifying complex karyotype as a prognostic and predictive biomarker. However, explicit recommendations for CBA and CMA methodology and clinical interpretation are still lacking. ERIC presents consensus on CBA/CMA and encourages their wide application in clinical trials to improve risk stratification and management, although CMA data is limited.

HEMASPHERE (2022)

Article Oncology

Ethnic and geographic diversity of chronic lymphocytic leukaemia

Shenmiao Yang et al.

Summary: East Asians, Asian Indians, and Amerindians have a significantly lower incidence rate of chronic lymphocytic leukemia compared to persons of European descent, suggesting a genetic rather than environmental basis for this disparity. These populations have different genetic admixtures with archaic hominins, potentially explaining the varying CLL incidences among them, as well as differences in clinical and molecular covariates of CLL. Further research is needed to determine the exact reasons behind these population variances in CLL and other lymphomas and cancers.

LEUKEMIA (2021)

Review Biochemistry & Molecular Biology

Chromosomes in the genomic age. Preserving cytogenomic competence of diagnostic genome laboratories

Ron Hochstenbach et al.

Summary: The participation of clinical genetic laboratories in External Quality Assessment schemes is crucial for identifying improvement needs in diagnostic services. Recent EQAs have shown variability in the competence of recognizing and interpreting cytogenetic aberrations that could impact patient management. Several trends that could affect cytogenomic competence are identified, including the upcoming retirement of experienced cytogeneticists, insufficient training programs, and the attractiveness of whole genome sequencing.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

Article Multidisciplinary Sciences

Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

Wei-Yu Lin et al.

Summary: The study conducted a genome-wide association analysis on European patients with AML, identifying genetic loci associated with the risk of developing the disease. The results shed light on potential functional genes involved in histone methylation and immune function in AML etiology.

NATURE COMMUNICATIONS (2021)

Article Oncology

Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias

Valentin Lestringant et al.

Summary: The study compared optical genome mapping (OGM) to standard techniques in detecting cytogenetic abnormalities in acute lymphoblastic leukemias (ALL). OGM showed higher accuracy and sensitivity, identifying anomalies not easily detectable by standard techniques.

GENES CHROMOSOMES & CANCER (2021)

Review Oncology

Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype

Thomas Chatzikonstantinou et al.

Summary: This study summarizes the clinical impact of cytogenetic complexity in chronic lymphocytic leukemia, highlighting the need for further research on the incorporation of complex karyotype in clinical practice.

FRONTIERS IN ONCOLOGY (2021)

Article Biotechnology & Applied Microbiology

Evaluation of MLPA as a comprehensive molecular cytogenetic tool to detect cytogenetic markers of chronic lymphocytic leukemia in Egyptian patients

Ola M. Eid et al.

Summary: The study found that using MLPA as the first screening platform followed by FISH technique for only the negative cases is the most appropriate approach for CLL diagnosis and prognosis. The MLPA results were highly consistent with FISH, and the MLPA probemix contains probes targeting other genomic areas known to be linked to CLL in addition to common CLL aberrations.

JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY (2021)

Review Genetics & Heredity

Long-read sequencing for rare human genetic diseases

Satomi Mitsuhashi et al.

JOURNAL OF HUMAN GENETICS (2020)

Article Medicine, Research & Experimental

Epidemiology and Etiology of Leukemia and Lymphoma

Jordan A. Baeker Bispo et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)

Editorial Material Biochemistry & Molecular Biology

Cytopostgenomics: What is it and how does it work?

Ivan Y. Iourov

CURRENT GENOMICS (2019)

Article Hematology

Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment

Michael Hallek

AMERICAN JOURNAL OF HEMATOLOGY (2019)

Review Oncology

Chronic lymphocytic leukaemia: from genetics to treatment

Francesc Bosch et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Multidisciplinary Sciences

Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics

Helen E. Speedy et al.

NATURE COMMUNICATIONS (2019)

Review Pathology

The Utilization of Chromosomal Microarray Technologies for Hematologic Neoplasms

Jess F. Peterson et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2018)

Review Medicine, General & Internal

Chronic lymphocytic leukaemia

Michael Hallek et al.

LANCET (2018)

Article Multidisciplinary Sciences

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

Phillip J. Law et al.

NATURE COMMUNICATIONS (2017)

Article Hematology

Epidemiological patterns of leukaemia in 184 countries: a population-based study

Adalberto Miranda-Filho et al.

Lancet Haematology (2017)

Review Medicine, General & Internal

Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

P. Baliakas et al.

JOURNAL OF INTERNAL MEDICINE (2016)

Article Multidisciplinary Sciences

Mutations driving CLL and their evolution in progression and relapse

Dan A. Landau et al.

NATURE (2015)

Article Biotechnology & Applied Microbiology

Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go

Anna Puiggros et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Article Oncology

Genetic differences between Asian and Caucasian chronic lymphocytic leukemia

Norihiko Kawamata et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2013)

Article Hematology

Genetic Susceptibility to Chronic Lymphocytic Leukemia

Susan L. Slager et al.

SEMINARS IN HEMATOLOGY (2013)

Review Oncology

Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease

Ana E. Rodriguez-Vicente et al.

CANCER GENETICS (2013)

Review Hematology

Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future

Jennifer R. Brown

THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)

Article Hematology

NOTCH1 mutations in CLL associated with trisomy 12

Veronica Balatti et al.

BLOOD (2012)

Review Biochemistry & Molecular Biology

Multiplex Ligation-dependent Probe Amplification (MLPA) in Tumor Diagnostics and Prognostics

Cornelia Homig-Holzel et al.

DIAGNOSTIC MOLECULAR PATHOLOGY (2012)

Article Oncology

Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia

Peter Ouillette et al.

GENES CHROMOSOMES & CANCER (2012)

Review Biochemistry & Molecular Biology

Use of the MLPA Assay in the Molecular Diagnosis of Gene Copy Number Alterations in Human Genetic Diseases

Liborio Stuppia et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)

Article Oncology

Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia

William G. Wierda et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Biochemistry & Molecular Biology

Somatic Mosaicism in Cases with Small Supernumerary Marker Chromosomes

Thomas Liehr et al.

CURRENT GENOMICS (2010)

Article Biochemistry & Molecular Biology

Ontogenetic Variation of the Human Genome

Y. B. Yurov et al.

CURRENT GENOMICS (2010)

Article Hematology

Familial chronic lymphocytic leukemia

Lynn R. Goldin et al.

CURRENT OPINION IN HEMATOLOGY (2010)

Review Oncology

From pathogenesis to treatment of chronic lymphocytic leukaemia

Thorsten Zenz et al.

NATURE REVIEWS CANCER (2010)

Article Oncology

Frequency of 5′IGH deletions in B-cell chronic lymphocytic leukemia

Fabiola Quintero-Rivera et al.

CANCER GENETICS AND CYTOGENETICS (2009)

Review Hematology

Whole genome scanning as a cytogenetic tool in hematologic malignancies

Jaroslaw P. Maciejewski et al.

BLOOD (2008)

Article Medicine, General & Internal

Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia

Andy C. Rawstron et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Pathology

Distribution of malignant lymphoma in Japan: Analysis of 2260 cases, 2001-2006

Ryosuke Aoki et al.

PATHOLOGY INTERNATIONAL (2008)

Review Hematology

Inherited predisposition to chronic lymphocytic leukemia

Jennifer R. Brown

EXPERT REVIEW OF HEMATOLOGY (2008)

Article Hematology

Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology

Graca A. M. Dores et al.

BRITISH JOURNAL OF HAEMATOLOGY (2007)

Review Cell Biology

Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation

Pawel Stankiewicz et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)

Article Oncology

Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia

Lorena Ripolles et al.

CANCER GENETICS AND CYTOGENETICS (2006)

Review Cell Biology

Chromosomics

U Claussen

CYTOGENETIC AND GENOME RESEARCH (2005)

Article Multidisciplinary Sciences

Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

GA Calin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Genetics & Heredity

Assembly of microarrays for genome-wide measurement of DNA copy number.

AM Snijders et al.

NATURE GENETICS (2001)

Article Hematology

Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan

K Tamura et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2001)

Article Medicine, General & Internal

Genomic aberrations and survival in chronic lymphocytic leukemia.

H Döhner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)